Turnover Talk: Molecular Testing and Patient Selection in Ovarian Cancer
A brief discussion of homologous recombination deficiency, loss of heterozygosity, and molecular markers in ovarian cancer, and how this can guide therapy.
Category
  • Turnover Talks
  • Ovary
  • Genetics
  • Targeted Therapy
Format
  • On-Demand
Credits